Delivery Order SPE2DE21D0005-SPE2D625F212L

Award Date 10/29/24
Potential Completion Date 11/1/24
Potential Value $5.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care and surgical biologics products. The contract, valued at $8,150.00, is for the delivery of PURAPLY MZ 500MG, a wound care product. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award Indefinite Delivery Contract...
This federal contract award, valued at $6,800.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The award is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, which has a total ceiling value of $49.5 million for wound care dressings, discs, and medical materials. The contract does not have a set-aside designation. The specific product being procured is PURAPLY...
The U.S. Department of Defense's Medical Supply Chain (Defense Logistics Agency Troop Support Medical) has awarded Organogenesis Inc. a $8,500.00 fixed-price delivery order contract (SPE2DE21D0005|SPE2D624F9CS2) for the supply of PURAPLY AM XT 4.91x4.91 medical products. This delivery order is part of Organogenesis' existing $49.5 million multiple-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency for wound care dressings, discs, and medical materials. Organogenesis is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
This federal contract award was issued by the Medical Supply Chain, a component of the Department of Defense's Defense Logistics Agency (DLA), to Organogenesis Inc., a for-profit manufacturer of regenerative medical products. The $1,140 fixed-price with economic price adjustment delivery order is for the supply of PURAPLY MZ 500MG, a wound care product. This award is not a set-aside contract. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The $8,500.00 fixed-price delivery order is for the procurement of medical supplies, specifically PURAPLY AM XT 4.91X4.91 wound dressings. The contract has a period of performance through July 23, 2024. Organogenesis is a long-standing federal contractor that specializes in the development and manufacture of advanced wound care and...
This $8,500 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Defense Logistics Agency (DLA) Troop Support Medical on September 11, 2024. The order is for the supply of PURAPLY AM XT, a wound care product, with an ultimate completion date of September 16, 2024. Organogenesis is a key supplier of advanced wound care and surgical biologics products to the U.S. government, primarily serving the Department of Defense and Department of Veterans...
This federal contract award, valued at $6,800.00, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract, which does not have a set-aside designation, is a Delivery Order for PURAPLY AM XT 4.91X4.91 medical supplies. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare agencies, particularly the Department of...
This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order is for PURAPLY AM wound care dressings, which are advanced skin substitutes used to support tissue repair and regeneration. Organogenesis is an experienced federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F212L
    Delivery Order

This federal contract award is a delivery order (SPE2DE21D0005|SPE2D625F212L) valued at $5,100.00, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is for the supply of PURAPLY AM XT 4.91X4.91, an advanced wound care product.

Organogenesis is a leading provider of regenerative medicine solutions to federal healthcare agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds several significant federal Indefinite Delivery Vehicles (IDVs), including a $25 million single-award Indefinite Delivery Contract with the VA Headquarters for surgical implants, a $30 million multiple-award Federal Supply Schedule contract with the VA for tissue regeneration products, and a $49.5 million multiple-award IDC with the DLA Troop Support Medical for wound care dressings and medical supplies. This latest delivery order supports the military medical supply chain by providing specialized wound care and tissue regeneration products to aid in the treatment of service members and veterans.

Generated 1/28/25, 12:16 PM